“Börsenradio: Exclusive interviews and market insights for investors”

2023-05-23 13:17:55

Börsenradio: top interviews directly from the market

news news-single">

23.05.2023, 15:17:55

Mr. Andreas Grassauer (CEO) in conversation with Peter Heinrich

CEO Andreas Grassauer: “With the product Carragelose you will get well twice as fast. The flu usually lasts 10 to 12 days. You can take the product beforehand, then the flu cannot spread. And the product is also effective against everyone 5 strains of corona virus. When coughs and colds are rampant, then we too are the beneficiaries. You shouldn’t underestimate the cold, even in summer.” – Q1/2023 figures: Sales up 38% to around EUR 3.3 million. The operating result was negative at minus EUR 1.4 million, as in the previous year. – Carragelose is an active ingredient that is extracted from red algae. It is used to support the treatment of colds caused by viruses. Carragelose forms a moisturizing protective film on the nasal and pharyngeal mucosa, which protects the mucous membrane barrier against cold viruses.

---

Discussed instruments

Marinomed Biotech AG

news-gray-box">

news-panel-chart" data-link="/?ID_NOTATION=244740791">

Marinomed Biotech AG

1 month

+2,66 %

YTD

-31,56 %

1 year

-51,63 %

The Vienna Stock Exchange Podcast is now available on all major podcast channels:

The interviews were conducted by Börsenradio.at and made available here in a Prime version.

1684899940
#Colds #flu #travel #world #Marinomed #Stock #market #relevant #news